GenAssist

BiotechnologySeries ASuzhou, Chinagenassisttx.com

Latest round

Series A

Last raised

Nov 2022

Total raised

$1.4M

Investors

4

About GenAssist

Based in Suzhou, China and established in 2020, GenAssist operates as a biotechnology company that engages in research and development of gene editing drug. The founder of the company, He Chunyan, PhD in Immunology from Shanghai Jiaotong University, worked in Fosun Group, Tasly Group, Sunshine Insurance and other companies. The CSO of the company, Dr. Xing Chang, works as an associate professor at Westlake University. The company specializes in the development of therapeutic drugs for neuromuscular diseases bases on TAM base editing technology platform. The company's first product is for Duchenne Muscular Dystrophy (DMD) series of gene mutation diseases. The company's product pipeline can be used to treat Duchenne muscular dystrophy.

Who invested in GenAssist

4 investors across 2 rounds

See all investors in GenAssist

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 18, 2022

    Amount

    $1.4M

    Investors

    Locked

  2. Angel

    Dec 22, 2020

    Amount

    Undisclosed

    Investors

    Locked

Questions about GenAssist

Who invested in GenAssist?

GenAssist has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GenAssist raised?

GenAssist has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did GenAssist last raise money?

GenAssist's most recent round on record is a Series A, in Nov 2022.

What does GenAssist do?

Based in Suzhou, China and established in 2020, GenAssist operates as a biotechnology company that engages in research and development of gene editing drug.

Where is GenAssist headquartered?

GenAssist is headquartered in Suzhou, China.

Which VCs invest in companies like GenAssist?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GenAssist's stage. Their profiles are linked below.

Raising like GenAssist? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.